logo

For the Inventor, By the Inventor

Santa Monica, CA, United States of America

Agensys, Inc.


USPTO Granted Patents = 199

% Expired Patents = 50.8



Trademarks = 3

Forward Citations = 1,302

Loading Chart...
Loading Chart...

61 inventors (with patents filed for the assignee):

goldMedal Arthur B Raitano (158 out of 164 patents)

silverMedal Aya Jakobovits (151 out of 191 patents)

bronzeMedal Pia M Challita-Eid (113 out of 113 patents)

4.  Rene S Hubert (110 out of 116 patents)

5.  Mary Faris (99 out of 104 patents)

6.  Karen Jane Meyrick Morrison (68 out of 68 patents)

7.  Wangmao Ge (68 out of 68 patents)

8.  Robert Kendall Morrison (62 out of 62 patents)

9.  Daniel E H Afar (55 out of 56 patents)

10.  Douglas C Saffran (34 out of 41 patents)

11.  Jean M Gudas (33 out of 49 patents)

12.  Xiao-Chi Jia (26 out of 57 patents)

13.  Daniel E Afar (25 out of 36 patents)

14.  Juan J Perez-Villar (23 out of 26 patents)

15.  Steve Chappell Mitchell (22 out of 22 patents)


Core Competencies:
Antibody Drug Conjugates
AXL Proteins
CD37 Proteins
FLT3 Proteins
Nucleic Acid Molecules
Tumor Associated Proteins
Prostate Cancer
Cancer Detection

199 patents:

1. 12612429 - Derivatives of dolaproine-dolaisoleuine peptides (2026-04-28),
2. 12552868 - ANTIBODIES THAT BIND TO AXL PROTEINS (2026-02-17),
3. 12545737 - ANTIBODIES THAT BIND TO AXL PROTEINS (2026-02-10),
4. 12257340 - Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof (2025-03-25),
5. 11739155 - Antibodies that bind to AXL proteins (2023-08-29),
6. 11718677 - Antibodies that bind to AXL proteins (2023-08-08),
7. 11634503 - Antibody drug conjugates (ADC) that bind to 158P1D7 proteins (2023-04-25),
8. 11633500 - Antibody drug conjugates (ADC) that bind to CD37 proteins (2023-04-25),
9. 11559582 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2023-01-24),
10. 11401347 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins (2022-08-02),
11. 11312748 - Derivatives of dolaproine-dolaisoleucine peptides (2022-04-26),
12. 11292837 - Nectin-4 binding proteins and methods of use thereof (2022-04-05),
13. 10894090 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2021-01-19),
14. RE48389 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2021-01-11),
15. 10787517 - Antibodies that bind to AXL proteins (2020-09-29),
Company Overview
Agensys, Inc., based in Santa Monica, CA, specializes in the development of innovative antibody drug conjugates (ADCs) aimed at treating various cancers. The company focuses on leveraging its expertise in AXL, CD37, and FLT3 proteins, along with nucleic acid molecules and tumor-associated proteins, to advance cancer detection and therapeutic strategies. Agensys is dedicated to addressing unmet medical needs in oncology, particularly in prostate cancer, through its cutting-edge research and technology initiatives.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Agensys, Inc. USPTO Patent Assignee Logo
199 Patents

#4 in Santa Monica, CA

#453 in California

#2,075 in US

#4,247 in the World

Santa Monica, CA (US)
Santa Monica, CA, United States of America

Agensys, Inc.

Forward Citations = 1,302

61 inventors:

goldMedal Arthur B Raitano (158 out of 164 patents)

silverMedal Aya Jakobovits (151 out of 191 patents)

bronzeMedal Pia M Challita-Eid (113 out of 113 patents)

4.  Rene S Hubert (110 out of 116 patents)

5.  Mary Faris (99 out of 104 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Agensys, Inc.. Retrieved from https://idiyas.com/company/agensys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…